Technical Analysis for SIGA - SIGA Technologies Inc.
Grade | Last Price | % Change | Price Change |
---|---|---|---|
A | 7.95 | 8.46% | 0.62 |
SIGA closed up 8.46 percent on Monday, March 18, 2024, on 3.53 times normal volume. The bulls were able to push the stock to a new 52-week high. Due to the stock's strong uptrend, it may remain overbought for a while. So, if you're looking for a reason to sell, don't put too much weight on it being overbought.
ADX | Long Term | Intermediate Term | Short Term |
---|---|---|---|
Strong | Up | Up | Up |
Date | Alert Name | Type | % Chg |
---|---|---|---|
New 52 Week Closing High | Bullish | 0.00% | |
Pocket Pivot | Bullish Swing Setup | 0.00% | |
Volume Surge | Other | 0.00% | |
Wide Range Bar | Range Expansion | 0.00% | |
New 52 Week High | Strength | 0.00% | |
Parabolic Rise | Strength | 0.00% | |
Upper Bollinger Band Walk | Strength | 0.00% | |
Wide Bands | Range Expansion | 0.00% | |
Above Upper BB | Strength | 0.00% | |
Gapped Up | Strength | 0.00% |
Alert | Time |
---|---|
60 Minute Opening Range Breakout | about 12 hours ago |
Down 1% | about 16 hours ago |
2x Volume Pace | about 16 hours ago |
1.5x Volume Pace | about 16 hours ago |
3x Volume Pace | about 16 hours ago |
Get a Trading Assistant
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Configure default chart indicators
Basic chart:
- Earnings date: 05/02/2024
SIGA Technologies, Inc. is a company specializing in the development and commercialization of solutions for serious unmet medical needs and biothreats. The company’s lead product is TPOXX®, also known as tecovirimat and ST-246®, an orally administered and IV formulation antiviral drug that targets orthopoxvirus infections. While TPOXX® is not yet approved as safe and effective by the U.S. Food & Drug Administration, it is a novel small-molecule drug of which 2 million courses have been delivered to the Strategic National Stockpile under Project BioShield.
Sector: Healthcare
Industry: Biotechnology
Keywords: Chemical Compounds Organic Chemistry Antiviral Drug Biological Warfare Small Molecule Monkeypox Poxviruses Orthopoxvirus
Classification
Sector: Healthcare
Industry: Biotechnology
Keywords: Chemical Compounds Organic Chemistry Antiviral Drug Biological Warfare Small Molecule Monkeypox Poxviruses Orthopoxvirus
Indicator | Bull Case | Neutral / Hold | Bear Case |
---|---|---|---|
50 DMA | |||
200 DMA | |||
ADX Trend | |||
Oversold / Overbought | |||
Relative Strength |
Indicator | Value |
---|---|
52 Week High | 7.96 |
52 Week Low | 4.215 |
Average Volume | 536,177 |
200-Day Moving Average | 5.22 |
50-Day Moving Average | 5.25 |
20-Day Moving Average | 5.54 |
10-Day Moving Average | 5.87 |
Average True Range | 0.37 |
RSI (14) | 85.03 |
ADX | 28.38 |
+DI | 54.50 |
-DI | 9.30 |
Chandelier Exit (Long, 3 ATRs) | 6.84 |
Chandelier Exit (Short, 3 ATRs) | 5.87 |
Upper Bollinger Bands | 7.26 |
Lower Bollinger Band | 3.83 |
Percent B (%b) | 1.2 |
BandWidth | 61.90 |
MACD Line | 0.49 |
MACD Signal Line | 0.19 |
MACD Histogram | 0.3025 |
Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
---|---|---|---|---|---|
Resistance 4 (R4) | 9.11 | ||||
Resistance 3 (R3) | 8.98 | 8.47 | 8.91 | ||
Resistance 2 (R2) | 8.47 | 8.18 | 8.53 | 8.85 | |
Resistance 1 (R1) | 8.21 | 7.99 | 8.34 | 8.34 | 8.78 |
Pivot Point | 7.70 | 7.70 | 7.77 | 7.76 | 7.70 |
Support 1 (S1) | 7.44 | 7.41 | 7.57 | 7.57 | 7.12 |
Support 2 (S2) | 6.93 | 7.22 | 6.99 | 7.05 | |
Support 3 (S3) | 6.67 | 6.93 | 6.99 | ||
Support 4 (S4) | 6.80 |